FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387500317> ?p ?o ?g. }

• W4387500317 abstract "ABSTRACT Nitroaromatic drugs are of critical importance for the treatment of trypanosome infections in Africa and the Americas. Fexinidazole recently joined benznidazole and nifurtimox in this family when it was approved as the first oral therapy against Human African trypanosomiasis (HAT). Nitroaromatic prodrugs are bioactivated by the trypanosome-specific type I nitroreductase (NTR) enzyme that renders the compounds trypanocidal. A caveat to the specificity of NTR activation is the potential for drug resistance and cross-resistance that can arise if NTR expression or functionality is altered through mutation. The outcomes of NTR bioactivation of nitroaromatic compounds is variable but can include the formation highly reactive open chain nitriles that can damage biomolecules including DNA. A proposed mechanism of action of nitroaromatic compounds is the formation of reactive oxygen species (ROS) resulting in the formation of trypanocidal levels of DNA damage. Fexinidazole made its way to clinical approval without a significant interrogation of its effects on trypanosome biology and a limited understanding of its mechanism of action. Early reports mentioned fexinidazole potentially affects DNA synthesis but without supporting data. In this study, we evaluated and compared the cytotoxic effects of nifurtimox, benznidazole, and fexinidazole on Trypanosoma brucei using in vitro analyses. Specifically, we sought to differentiate between the proposed effects of nitroaromatics on DNA damage and DNA synthesis. Toward this goal we generated a novel γH2A-based flow cytometry assay that reports DNA damage formation in conjunction with cell cycle progression. Here we report that fexinidazole’s cytotoxic outcomes are distinct from the related drugs nifurtimox and benznidazole. Specifically, we show that fexinidazole treatment results in a pronounced defect in DNA synthesis that reduces the population of parasites in S phase. In contrast, treatment with nifurtimox and benznidazole appear accumulate DNA damage early in cell cycle and result in a defective G 2 population. The findings presented here bring us closer to understanding the anti-trypanosomatid mechanisms of action of nitroaromatic compounds, which will promote improved drug design and help combat potential drug resistance in the future. Our findings also highlight DNA synthesis inhibition as a powerful anti-parasitic drug target." @default.
• W4387500317 created "2023-10-11" @default.
• W4387500317 creator A5046710463 @default.
• W4387500317 creator A5046916098 @default.
• W4387500317 creator A5073206652 @default.
• W4387500317 creator A5075259826 @default.
• W4387500317 date "2023-10-09" @default.
• W4387500317 modified "2023-10-15" @default.
• W4387500317 title "Fexinidazole induced cytotoxicity is distinct from related anti-trypanosome nitroaromatic drugs" @default.
• W4387500317 cites W10910567 @default.
• W4387500317 cites W1867253423 @default.
• W4387500317 cites W1967138380 @default.
• W4387500317 cites W1972038608 @default.
• W4387500317 cites W1978737769 @default.
• W4387500317 cites W1979391949 @default.
• W4387500317 cites W1985775217 @default.
• W4387500317 cites W1986157017 @default.
• W4387500317 cites W1991297784 @default.
• W4387500317 cites W2006050756 @default.
• W4387500317 cites W2007321086 @default.
• W4387500317 cites W2016292622 @default.
• W4387500317 cites W2031081673 @default.
• W4387500317 cites W2064173649 @default.
• W4387500317 cites W2070034593 @default.
• W4387500317 cites W2074978170 @default.
• W4387500317 cites W2077432316 @default.
• W4387500317 cites W2077451644 @default.
• W4387500317 cites W2081414531 @default.
• W4387500317 cites W2087058910 @default.
• W4387500317 cites W2090150963 @default.
• W4387500317 cites W2116350092 @default.
• W4387500317 cites W2145351914 @default.
• W4387500317 cites W2149739510 @default.
• W4387500317 cites W2154091540 @default.
• W4387500317 cites W2227520693 @default.
• W4387500317 cites W2592102995 @default.
• W4387500317 cites W2614952490 @default.
• W4387500317 cites W269249036 @default.
• W4387500317 cites W2800884582 @default.
• W4387500317 cites W2908991243 @default.
• W4387500317 cites W2950862121 @default.
• W4387500317 cites W2974908100 @default.
• W4387500317 cites W2980604111 @default.
• W4387500317 cites W3130226341 @default.
• W4387500317 cites W3164474574 @default.
• W4387500317 cites W3176042341 @default.
• W4387500317 cites W4292649135 @default.
• W4387500317 cites W4310273466 @default.
• W4387500317 doi "https://doi.org/10.1101/2023.10.09.561529" @default.
• W4387500317 hasPublicationYear "2023" @default.
• W4387500317 type Work @default.
• W4387500317 citedByCount "0" @default.
• W4387500317 crossrefType "posted-content" @default.
• W4387500317 hasAuthorship W4387500317A5046710463 @default.
• W4387500317 hasAuthorship W4387500317A5046916098 @default.
• W4387500317 hasAuthorship W4387500317A5073206652 @default.
• W4387500317 hasAuthorship W4387500317A5075259826 @default.
• W4387500317 hasBestOaLocation W43875003171 @default.
• W4387500317 hasConcept C104317684 @default.
• W4387500317 hasConcept C108215921 @default.
• W4387500317 hasConcept C109316439 @default.
• W4387500317 hasConcept C136764020 @default.
• W4387500317 hasConcept C143425029 @default.
• W4387500317 hasConcept C178790620 @default.
• W4387500317 hasConcept C185592680 @default.
• W4387500317 hasConcept C202751555 @default.
• W4387500317 hasConcept C2776120743 @default.
• W4387500317 hasConcept C2776171842 @default.
• W4387500317 hasConcept C2776684476 @default.
• W4387500317 hasConcept C2777625466 @default.
• W4387500317 hasConcept C2778959862 @default.
• W4387500317 hasConcept C2779502636 @default.
• W4387500317 hasConcept C2780035454 @default.
• W4387500317 hasConcept C2781049234 @default.
• W4387500317 hasConcept C29730261 @default.
• W4387500317 hasConcept C41008148 @default.
• W4387500317 hasConcept C48349386 @default.
• W4387500317 hasConcept C552990157 @default.
• W4387500317 hasConcept C55493867 @default.
• W4387500317 hasConcept C71928629 @default.
• W4387500317 hasConcept C86803240 @default.
• W4387500317 hasConcept C98274493 @default.
• W4387500317 hasConceptScore W4387500317C104317684 @default.
• W4387500317 hasConceptScore W4387500317C108215921 @default.
• W4387500317 hasConceptScore W4387500317C109316439 @default.
• W4387500317 hasConceptScore W4387500317C136764020 @default.
• W4387500317 hasConceptScore W4387500317C143425029 @default.
• W4387500317 hasConceptScore W4387500317C178790620 @default.
• W4387500317 hasConceptScore W4387500317C185592680 @default.
• W4387500317 hasConceptScore W4387500317C202751555 @default.
• W4387500317 hasConceptScore W4387500317C2776120743 @default.
• W4387500317 hasConceptScore W4387500317C2776171842 @default.
• W4387500317 hasConceptScore W4387500317C2776684476 @default.
• W4387500317 hasConceptScore W4387500317C2777625466 @default.
• W4387500317 hasConceptScore W4387500317C2778959862 @default.
• W4387500317 hasConceptScore W4387500317C2779502636 @default.
• W4387500317 hasConceptScore W4387500317C2780035454 @default.
• W4387500317 hasConceptScore W4387500317C2781049234 @default.
• W4387500317 hasConceptScore W4387500317C29730261 @default.
• W4387500317 hasConceptScore W4387500317C41008148 @default.

• next